Support and training for youth at risk of psychosis
InVEST: Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (CHR-P)
This study is testing a program called InVEST to help young people aged 12-18 who are at risk for psychosis improve their school and work skills with the support of friendly coaches, making it easier for them to tackle challenges and stay engaged in their education and jobs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10640940 on NIH RePORTER |
What this research studies
This research focuses on developing an intervention called InVEST, which aims to improve educational and vocational functioning for youth aged 12-18 who are at clinical high risk for psychosis. The program is delivered by trained coaches and addresses key challenges such as executive functioning difficulties, stress sensitivity, and task initiation issues. By providing individualized support, InVEST seeks to enhance engagement in academic and vocational pursuits, which are critical during this vulnerable developmental stage. The intervention can be conducted in person or via videoconference, making it accessible to participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth aged 12-18 who are exhibiting clinical high risk for psychosis.
Not a fit: Patients who are not in the age range of 12-18 or who do not exhibit clinical high risk for psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve educational outcomes and vocational engagement for young individuals at risk of developing psychosis.
How similar studies have performed: Previous research has shown success with similar interventions aimed at improving functional outcomes in youth at risk for mental health issues, making this approach promising.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Friedman-Yakoobian, Michelle S — Beth Israel Deaconess Medical Center
- Study coordinator: Friedman-Yakoobian, Michelle S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.